{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:50:13Z","timestamp":1791186613935,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":3272,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuron"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.neuron.2004.07.003","type":"journal-article","created":{"date-parts":[[2004,8,5]],"date-time":"2004-08-05T15:43:53Z","timestamp":1091720633000},"page":"321-332","source":"Crossref","is-referenced-by-count":644,"title":["A\u03b2 Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the Proteasome"],"prefix":"10.1016","volume":"43","author":[{"given":"Salvatore","family":"Oddo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Billings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.Patrick","family":"Kesslak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Cribbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"LaFerla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuron.2004.07.003_BIB1","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","article-title":"Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease","volume":"6","author":"Bard","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuron.2004.07.003_BIB2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/415462a","article-title":"Nerve inflammation halts trial for Alzheimer's drug","volume":"415","author":"Check","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2004.07.003_BIB3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1046\/j.1471-4159.2002.01137.x","article-title":"Proteasomal degradation of tau protein","volume":"83","author":"David","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuron.2004.07.003_BIB4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nn842","article-title":"Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model","volume":"5","author":"Dodart","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2004.07.003_BIB5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1471-4159.2001.00012.x","article-title":"Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain","volume":"76","author":"Dovey","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuron.2004.07.003_BIB6","doi-asserted-by":"crossref","first-page":"8872","DOI":"10.1523\/JNEUROSCI.23-26-08872.2003","article-title":"Proteasome inhibition stabilizes tau inclusions in oligodendroglial cells that occur after treatment with okadaic acid","volume":"23","author":"Goldbaum","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2004.07.003_BIB7","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nature02263","article-title":"Protein degradation and protection against misfolded or damaged proteins","volume":"426","author":"Goldberg","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2004.07.003_BIB8","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1062097","article-title":"Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils","volume":"293","author":"Gotz","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuron.2004.07.003_BIB9","doi-asserted-by":"crossref","first-page":"19702","DOI":"10.1074\/jbc.270.34.19702","article-title":"Amyloid beta-protein inhibits ubiquitin-dependent protein degradation in vitro","volume":"270","author":"Gregori","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuron.2004.07.003_BIB10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1074\/jbc.272.1.58","article-title":"Binding of amyloid beta protein to the 20 S proteasome","volume":"272","author":"Gregori","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuron.2004.07.003_BIB11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuron.2004.07.003_BIB12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0896-6273(03)00294-0","article-title":"Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease","volume":"38","author":"Hock","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2004.07.003_BIB13","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","article-title":"Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17","volume":"393","author":"Hutton","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2004.07.003_BIB14","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/35050110","article-title":"A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease","volume":"408","author":"Janus","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2004.07.003_BIB15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1471-4159.2003.01642.x","article-title":"Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease","volume":"85","author":"Keck","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuron.2004.07.003_BIB16","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1471-4159.2000.0750436.x","article-title":"Impaired proteasome function in Alzheimer's disease","volume":"75","author":"Keller","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuron.2004.07.003_BIB17","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1124\/jpet.102.048280","article-title":"The gamma-secretase inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester reduces A beta levels in vivo in plasma and cerebrospinal fluid in young (plaque-free) and aged (plaque-bearing) Tg2576 mice","volume":"305","author":"Lanz","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuron.2004.07.003_BIB18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","article-title":"Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP","volume":"293","author":"Lewis","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuron.2004.07.003_BIB19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nbt851","article-title":"A transgenic mouse model of the ubiquitin\/proteasome system","volume":"21","author":"Lindsten","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuron.2004.07.003_BIB20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1097-4547(20001015)62:2<302::AID-JNR15>3.0.CO;2-L","article-title":"Defective ubiquitination of cerebral proteins in Alzheimer's disease","volume":"62","author":"Lopez Salon","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuron.2004.07.003_BIB21","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/archneur.1991.00530240033013","article-title":"Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments","volume":"48","author":"Mendell","year":"1991","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuron.2004.07.003_BIB22","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/35050116","article-title":"A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease","volume":"408","author":"Morgan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2004.07.003_BIB23","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm840","article-title":"Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide","volume":"9","author":"Nicoll","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuron.2004.07.003_BIB24","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","article-title":"Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease","volume":"24","author":"Oddo","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuron.2004.07.003_BIB25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2004.07.003_BIB26","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1073\/pnas.092136199","article-title":"Tau is essential to beta-amyloid-induced neurotoxicity","volume":"99","author":"Rapoport","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2004.07.003_BIB27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI200420640","article-title":"Caspase-cleavage of tau is an early event in neurofibrillary pathology in Alzheimer's disease","volume":"114","author":"Rissman","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuron.2004.07.003_BIB28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2004.07.003_BIB29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9440(10)61715-4","article-title":"Immunization with a nontoxic\/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice","volume":"159","author":"Sigurdsson","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuron.2004.07.003_BIB30","article-title":"Amyloid [beta]-peptide","volume":"in press","author":"Tseng","year":"2004","journal-title":"Curr. Alzheimer's Res."},{"key":"10.1016\/j.neuron.2004.07.003_BIB31","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0197-4580(00)00157-3","article-title":"Conformational change as one of the earliest alterations of tau in Alzheimer's disease","volume":"21","author":"Weaver","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuron.2004.07.003_BIB32","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1523\/JNEUROSCI.23-09-03745.2003","article-title":"Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation","volume":"23","author":"Wilcock","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2004.07.003_BIB33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nbd.2003.09.015","article-title":"Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration","volume":"15","author":"Wilcock","year":"2004","journal-title":"Neurobiol. Dis."}],"container-title":["Neuron"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896627304004246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896627304004246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T20:59:21Z","timestamp":1549313961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896627304004246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0896627304004246"],"URL":"https:\/\/doi.org\/10.1016\/j.neuron.2004.07.003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1020609.239554","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1020609.239434","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1020609.232693","asserted-by":"object"}]},"ISSN":["0896-6273"],"issn-type":[{"value":"0896-6273","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}